How Long Do Reconstituted Peptides Last?
An approved product has an in-use period because somebody ran the stability study. For most peptides nobody did, and the numbers online come from elsewhere.
There is a version of this question that has a clean answer and a version that does not, and almost everyone asking is asking the second one while hoping for the first.
The clean version: how long does an approved, licensed, manufactured product last after you first use it? That is on the label, and it is there because a manufacturer ran stability studies and a regulator reviewed them.
The other version: how long does a vial of something with no marketing authorisation last after you reconstitute it? That question has no established answer, and the confident numbers attached to it online came from somewhere other than a study of that compound.
What an in-use period actually is
When a label says a product may be used for a set period after first use, that number is an output of testing. Samples were held under defined conditions, assayed at intervals, and the period was set where active content and impurity levels stayed inside specification.
The Ozempic pen carries an in-use period of 56 days after first use, stored either at controlled room temperature or in a refrigerator, and not frozen.
That figure is not a guess about how long semaglutide “generally” survives. It is a finding about a specific formulation, in a specific container, under specific conditions. Change the formulation, the container or the conditions and the number does not come with you.
This is the part that does not transfer to a research-chemical vial. The number on an approved product’s label describes that product. It is not a property of the molecule.
Where a compound has no approved product at all, there is no in-use period to quote — not a shorter one, not a longer one, none. The honest description of that situation is that it is unknown, and the figures circulating are conventions rather than findings.
Why the dry vial is the stable one
Peptides are supplied as lyophilised powder for a reason. Removing water removes the medium in which most degradation chemistry happens.
The reactions that break peptides down — deamidation, oxidation, hydrolysis, aggregation — largely need water to proceed at any speed. A properly stored dry powder is comparatively stable. The same peptide in solution is not.
The difference between the two states is the single largest factor here, and it means the clock that matters starts at reconstitution, not at purchase. A vial that sat dry for a year and was mixed yesterday is a one-day-old solution.
What actually shortens the window
Temperature. Degradation chemistry runs faster warm. This is why refrigerated storage is the standard instruction for solutions and why leaving a vial in a car is worse than it sounds.
Freezing. Counter-intuitively, freezing a peptide solution is not “extra refrigeration.” Ice formation concentrates solutes in the remaining liquid and creates ice-water interfaces, both of which can drive aggregation. Labels that permit refrigeration commonly prohibit freezing for exactly this reason.
Light. Some residues, particularly tryptophan and tyrosine, are photosensitive. Vials are usually supplied in materials that limit this; leaving one on a windowsill defeats it.
Agitation. Shaking a solution creates air-liquid interfaces where proteins unfold and aggregate. This is why reconstitution instructions generally say to direct the diluent down the vial wall and to swirl rather than shake.
Needle entries. Every pass through the stopper is an opportunity to introduce contamination. This one is not about the molecule at all, and it is the reason the choice of diluent matters.
Bacteriostatic versus sterile water
These are not interchangeable, and the difference is specifically about how many times the vial will be entered.
Bacteriostatic water contains a preservative, usually benzyl alcohol, which inhibits bacterial growth. It is intended for multi-dose use: the preservative is what makes a second and third entry defensible.
Sterile water contains no preservative. It is sterile when manufactured and has nothing maintaining that afterwards. A vial reconstituted with sterile water and entered repeatedly has no defence against organisms introduced on entry.
Two consequences follow. First, the diluent choice is not a preference — it follows from whether the vial is single-use or multi-dose. Second, benzyl alcohol is not inert; it is a reason some populations are advised against preserved diluents, and that is a prescriber’s question rather than a forum’s.
Note also that a preservative addresses microbial growth. It does nothing about chemical degradation of the peptide. The two clocks run independently.
Why “it looked fine” is not evidence
Cloudiness, visible particles and discolouration are genuine warning signs, and a vial showing any of them should not be used.
But their absence establishes very little. Deamidation, oxidation and much aggregation can reduce active content substantially while the solution stays perfectly clear. A peptide that has lost a large fraction of its potency looks exactly like one that has not.
This is precisely why in-use periods are expressed as dates rather than as an instruction to inspect the vial before each use. Inspection catches the obvious failures. It does not catch the common ones.
The honest answer
For an approved product, read the label. The number there is real, specific, and was produced by testing the actual product you are holding.
For everything else, there is no established beyond-use date, and the widely repeated figures are conventions carried over from other contexts rather than findings about the compound. Anyone quoting a precise number for an unapproved peptide is quoting something whose origin they probably cannot name.
What follows from that is not a different number. It is that the date of reconstitution and the concentration are the two facts worth recording, because they are the only inputs to the decision that you actually control and can verify.
The practical part
The dry vial has a printed expiry. The reconstituted one has a date that exists only if somebody wrote it down.
That is the failure mode in practice: not that people choose the wrong window, but that three weeks later nobody can say for certain which day the diluent went in, and the estimate quietly becomes optimistic. The reconstitution arithmetic and the calculator settle the concentration. The date is the other half, and it is the half that gets lost.
Write down the concentration, the diluent used, and the day it was mixed. Those three, together, are the record. Any one of them alone is an anecdote.
Frequently asked questions
How long does a reconstituted peptide last?
For an approved medicine, the label answers this because a manufacturer ran stability studies and a regulator reviewed them. The Ozempic pen, for example, carries an in-use period of 56 days after first use, stored either at controlled room temperature or refrigerated. For a compound with no marketing authorisation, no equivalent number exists — not because it is secret, but because the study was never done on that product. The figures circulating in forums are conventions borrowed from other contexts. They are not compound-specific findings, and treating them as though they were is the actual error.
Why does bacteriostatic water matter for this?
Because it is the difference between a vial designed to be entered once and one designed to be entered repeatedly. Bacteriostatic water contains a preservative, typically benzyl alcohol, which inhibits the growth of bacteria introduced when a needle passes through the stopper. Sterile water contains no preservative: it is sterile at the moment of manufacture and has nothing to keep it that way afterwards. A multi-dose vial reconstituted with sterile water has no defence against contamination introduced on the second entry, which is a separate problem from whether the peptide molecule itself has degraded.
Can I tell whether a peptide has degraded by looking at it?
Usually not. Visible changes — cloudiness, particles, discolouration — are real warning signs and a vial showing them should not be used. But the absence of those signs proves very little. Peptide degradation happens through processes like deamidation, oxidation and aggregation that can substantially reduce active content while the solution still looks completely clear. "It looked fine" is an observation about appearance, not about potency. This is the main reason in-use periods exist as dates rather than as instructions to inspect the vial.
Does refrigeration extend the window indefinitely?
No. Lower temperature slows most degradation chemistry, which is why refrigerated storage is the standard instruction, but slowing is not stopping. Two things also work against the assumption. Freezing and thawing can damage peptides in solution through mechanisms that have nothing to do with temperature averages, which is why labels that permit refrigeration often prohibit freezing outright. And refrigeration does nothing about contamination introduced by a needle. A cold vial that was contaminated on entry is a cold contaminated vial.